ImGTS for Patients With Behavioral and Psychological Symptoms of Dementia (Phase 2)
NCT ID: NCT06072014
Last Updated: 2023-10-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
30 participants
INTERVENTIONAL
2023-07-10
2023-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
ImGTS for Patients With Behavioral and Psychological Symptoms of Dementia
NCT05265182
Testing the Implementation of EIT-4-BPSD
NCT03014570
Virtual Reality Intervention for the Reduction of Behavioral and Psychological Symptoms of Dementia
NCT04769024
Development of An Exergame for Caregivers of Individuals With Alzheimer's Disease or Related Dementias
NCT03124550
Reducing Behavioral and Psychological Symptoms of Dementia: Hospital Caregivers (Aim 2)
NCT04179721
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Head-mounted display (HMD)
The HMD system uses a commercially available virtual headset, the Oculus/Meta Quest 2, which allows a user to view a virtual environment in 360 degrees and to interact with the environment using hand-tracking technology (i.e., when a user's hand is projected into the virtual world to be used for interactions and gestures).
Virtual reality
A role-playing game with activities based on existing therapy activities (such as orientation therapy, reminiscence therapy, art therapy, and music therapy) that are used to manage behavioral and psychological symptoms of dementia
Semi-cave automatic virtual environment (semi-CAVE)
The semi-CAVE system uses projectors and projector screens to provide a 270-degree view of the virtual environment. These projectors are connected to a powerful workstation (desktop computer), which uses HTC Vive trackers and base stations to track user movements and interactions
Virtual reality
A role-playing game with activities based on existing therapy activities (such as orientation therapy, reminiscence therapy, art therapy, and music therapy) that are used to manage behavioral and psychological symptoms of dementia
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Virtual reality
A role-playing game with activities based on existing therapy activities (such as orientation therapy, reminiscence therapy, art therapy, and music therapy) that are used to manage behavioral and psychological symptoms of dementia
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosed with mild to moderate Alzheimer's dementia according to the National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer's Disease and Related Disorders Association (NINCDS-ADRDA) criteria
* Montreal Cognitive Assessment-Philippines (MOCA-P) score of 10-20 inclusive
* Neuropsychiatric Inventory (NPI-12) score 1-50 inclusive
* Reisberg Scale Stage 4-5 inclusive
* Stable dose of antidepressants for the past 6 weeks
* Stable dose of antipsychotics for the past 4 weeks
* Able to walk unassisted or with minimal assistance, with or without assistive device
* No other explanation for condition based on reasonable clinical diagnostics
Exclusion Criteria
* Have MOCA-P score less than 10 or more than 20
* Other non-amnestic dementia syndromes
* Have receptive aphasia
* Have significant visual or hearing impairment
* Have an active psychiatric disorder prior to Alzheimer dementia diagnosis
* Had previous episodes of seizures, diagnosis of epilepsy, or intake of antiepileptic or seizure medications
* Have quadriplegia or paralysis of the dominant hand
* Have a history of motion sickness
* Experience claustrophobia
* Have a diagnosis of a terminal illness or a life expectancy of less than one year
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Augmented eXperience E-health Laboratory
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Veeda Michelle M. Anlacan, MD
Role: PRINCIPAL_INVESTIGATOR
University of the Philippines Manila
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of the Philippines College of Allied Medical Professions Immersive Technology Laboratory
Manila, National Capital Region, Philippines
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Anlacan, V.M.M. et al. (2023). Application Design for a Virtual Reality Therapy Game for Patients with Behavioral and Psychological Symptoms of Dementia. In: Krouska, A., Troussas, C., Caro, J. (eds) Novel & Intelligent Digital Systems: Proceedings of the 2nd International Conference (NiDS 2022). NiDS 2022. Lecture Notes in Networks and Systems, vol 556. Springer, Cham. https://doi.org/10.1007/978-3-031-17601-2_15
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AXEL0003
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.